Better informed, better care. #MedPageToday Retweets, likes, and comments are not endorsements.
New York, NY
Joined November 2008
- Tweets63.4K
- Following5.8K
- Followers73.5K
- Likes11K
Pinned Tweet
In order to foster a safe and respectful space for our community, we ask that users adhere to these guidelines when commenting.
Thread belowš§µā¬ļø
During an appointment with her psychiatrist, a 50-year-old woman with bipolar disorder reported new symptoms of tremor in both hands, slurred speech, and blurred vision.
Read more at: medpagetoday.com/casestudiesā¦
People with long COVID reported significantly better functioning and symptom improvements after taking low-dose naltrexone, according to a small retrospective cohort study.
Read more at: medpagetoday.com/meetingcoveā¦
Patients with MET-altered advanced non-small cell lung cancer lived significantly longer with a targeted combination after progression on standard-of-care osimertinib (Tagrisso), a large randomized trial showed. #ESMO26
medpagetoday.com/meetingcoveā¦
ICYMI: āImplication for risk #mitigation.ā @AmJNurs #nursingessentials #nursing
Read more: shorturl.at/6sFKA
Nearly one in 10 adults hospitalized with respiratory syncytial virus (RSV) infection died in the hospital or within 30 days of discharge, according to a CDC analysis of eight RSV seasons.
Read more at: medpagetoday.com/meetingcoveā¦
A pneumococcal conjugate vaccine covering 25 serotypes was safe and generated immune responses among infants that were comparable to the current 20-valent vaccine (Prevnar 20), a phase II trial showed.
medpagetoday.com/meetingcoveā¦
Should we let robots be doctors? š¤š©ŗ
According to @ZekeEmanuel, physicians "need to be willing to experiment with models that put AI in control."
Join us for a LIVE conversation on October 29 at 12:30 pm ET -- register now: ehgroup.zoom.us/webinar/regiā¦ @jeremyfaust
Supplementation with high-dose cholecalciferol (vitamin D3) did not improve overall survival in patients receiving dialysis for end-stage kidney disease, according to findings from the SIMPLIFIED trial. #KidneyWk @ASNKidney medpagetoday.com/meetingcoveā¦
A next-generation KRAS G12C inhibitor significantly improved survival outcomes versus first-generation drugs for previously treated advanced or metastatic non-small cell lung cancer, a phase III trial showed.
Read more at: medpagetoday.com/meetingcoveā¦
Strict dietary protein restriction was associated with worse clinical outcomes in patients with CKD who were not dependent on dialysis, a South Korean prospective cohort study suggested. #KidneyWk @ASNKidney medpagetoday.com/meetingcoveā¦
MS patients exposed to a GLP-1 receptor agonist had lower rates of relapse activity & steroid use, reduced incidence of optic neuritis, & fewer demyelinating events compared with those who didn't use these agents, a real-world study showed. medpagetoday.com/meetingcoveā¦
Perioperative treatment with durvalumab + neoadjuvant EV significantly improved EFS & OS compared with radical cystectomy in patients with MIBC who can't, or won't, tolerate cisplatin-based chemotherapy, according to the VOLGA trial. #ESMO26 @MichvdHeijden medpagetoday.com/meetingcoveā¦
Patients with heavily pretreated HR-positive breast cancer lived twice as long without disease progression with the novel ADC iza-bren, a randomized trial from China showed. #ESMO26 @myESMO medpagetoday.com/meetingcoveā¦
Twice daily oral doses of 100 mg of the BTK inhibitor remibrutinib reduced relapses more than teriflunomide (Aubagio) in patients with relapsing MS, data from two identical phase III studies showed. #MSToronto2026 @ECTRIMS medpagetoday.com/meetingcoveā¦
The investigational CD19-directed CAR T-cell therapy zola-cel showed the potential to treat people with highly active relapsing MS and progressive MS in a phase I study, but a fatal event occurred during the trial. #MSToronto2026 @ECTRIMS medpagetoday.com/meetingcoveā¦
Endovascular therapy made promising forays into milder and later-presenting large vessel occlusion strokes in a pair of multicenter, open-label trials from China. medpagetoday.com/cardiology/ā¦
Daily low-dose aspirin did not significantly reduce major vascular events in adults with chronic kidney disease, the randomized ATTACK trial showed. @ASNKidney #KidneyWk medpagetoday.com/meetingcoveā¦
Overall survival in ES-SCLC approached 2 years with tarlatamab (Imdelltra) combination maintenance therapy after first-line chemoimmunotherapy, a large randomized trial showed. #ESMO26 @myESMO @sands_jacob @StephenVLiu medpagetoday.com/meetingcoveā¦
Estrogen-only menopausal hormone therapy was associated with a slightly higher incidence of autoimmune disease compared with estrogen-progestogen therapy, a retrospective cohort study suggested.
Read more at: medpagetoday.com/meetingcoveā¦
Significant proteinuria reductions were reported in phase III interim analyses assessing two investigational IgA nephropathy agents and a third that was recently granted accelerated approval. #KidneyWk @ASNKidney medpagetoday.com/meetingcoveā¦
